Wells Fargo’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-84,856	Closed	-$768K	–	6101
2013 Q4	$768K	Buy	84,856 +8,474	+11%	+$76.7K	﹤0.01%	3550
2013 Q3	$481K	Buy	76,382 +63,682	+501%	+$401K	﹤0.01%	3754
2013 Q2	$87K	Buy	+12,700	New	+$87K	﹤0.01%	4393